Current management of hepatocellular carcinoma
- PMID: 19577120
- DOI: 10.1016/j.mcna.2009.03.004
Current management of hepatocellular carcinoma
Abstract
Hepatocellular carcinoma (HCC), one of the most common cancers worldwide, continues to increase in incidence in several regions around the world and is associated with poor overall survival. Patients with cirrhosis are at the highest risk and are candidates for surveillance. Wide implementation of surveillance programs and improvement in noninvasive radiologic techniques has led to tumor diagnosis at earlier stages. Surgical options that include resection and liver transplantation offer the best chance of successful outcomes. Locoregional therapies, such as radiofrequency ablation and chemoembolization, provide effective local control in those with acceptable hepatic function. A multikinase inhibitor, sorafenib, is the first molecular targeted oral therapy that has recently been shown to provide a survival benefit in HCC in select patients.
Similar articles
-
Surgical resection and liver transplantation for hepatocellular carcinoma.Clin Liver Dis. 2015 May;19(2):381-99. doi: 10.1016/j.cld.2015.01.007. Epub 2015 Mar 2. Clin Liver Dis. 2015. PMID: 25921669 Review.
-
Hepatocellular carcinoma.Lancet. 2012 Mar 31;379(9822):1245-55. doi: 10.1016/S0140-6736(11)61347-0. Epub 2012 Feb 20. Lancet. 2012. PMID: 22353262 Review.
-
[Nonsurgical management of hepatocellular carcinoma].Cancer Radiother. 2010 Oct;14(6-7):469-73. doi: 10.1016/j.canrad.2010.07.228. Epub 2010 Aug 23. Cancer Radiother. 2010. PMID: 20739209 Review. French.
-
[Current therapy for hepatocellular carcinoma].Nihon Rinsho. 2010 Jun;68(6):1129-36. Nihon Rinsho. 2010. PMID: 20535967 Review. Japanese.
-
Major achievements in hepatocellular carcinoma.Lancet. 2009 Feb 21;373(9664):614-6. doi: 10.1016/S0140-6736(09)60381-0. Lancet. 2009. PMID: 19231618 No abstract available.
Cited by
-
Prognostic value of SPARC in hepatocellular carcinoma: A systematic review and meta-analysis.PLoS One. 2022 Aug 18;17(8):e0273317. doi: 10.1371/journal.pone.0273317. eCollection 2022. PLoS One. 2022. PMID: 35981080 Free PMC article.
-
Portal Vein Tumor Thrombosis and Hepatocellular Carcinoma - The Changing Tides.J Hepatocell Carcinoma. 2021 Sep 7;8:1089-1115. doi: 10.2147/JHC.S318070. eCollection 2021. J Hepatocell Carcinoma. 2021. PMID: 34522691 Free PMC article. Review.
-
Single-cell RNA sequencing reveals the mechanism of sonodynamic therapy combined with a RAS inhibitor in the setting of hepatocellular carcinoma.J Nanobiotechnology. 2021 Jun 12;19(1):177. doi: 10.1186/s12951-021-00923-3. J Nanobiotechnology. 2021. PMID: 34118951 Free PMC article.
-
CREB5 promotes cell proliferation and correlates with poor prognosis in hepatocellular carcinoma.Int J Clin Exp Pathol. 2018 Oct 1;11(10):4908-4916. eCollection 2018. Int J Clin Exp Pathol. 2018. PMID: 31949566 Free PMC article.
-
Exosomes derived from rAAV/AFP-transfected dendritic cells elicit specific T cell-mediated immune responses against hepatocellular carcinoma.Cancer Manag Res. 2018 Oct 29;10:4945-4957. doi: 10.2147/CMAR.S178326. eCollection 2018. Cancer Manag Res. 2018. PMID: 30464595 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical